JohnPSheehanMD
Hematology • Madison, WIClotting Disorder, Hemophilia & Bleeding Disorder
Professor of Medicine, University of Wisconsin School of Medicine and Public Health
Dr. Sheehan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
600 Highland Ave
Madison, WI 53792Phone+1 608-265-1700Fax+1 608-266-6020
Summary
- I am a board certified hematologist and physician-scientist with interests in both clinical hematology and basic aspects of hemostasis and thrombosis.
Education & Training
Washington University/B-JH/SLCH ConsortiumFellowship, Hematology and Medical Oncology, 1989 - 1994
University of MinnesotaResidency, Internal Medicine, 1985 - 1988
University of Missouri-Columbia School of MedicineClass of 1985, M.D.
Certifications & Licensure
WI State Medical License 2001 - 2025
IL State Medical License 2011 - 2017
TX State Medical License 1996 - 2004
MN State Medical License 1988 - 1989- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011
Clinical Trials
- Study to Test the Safety and How Well Patients With Severe Hemophilia A Respond to Treatment With BAY 2599023 (DTX 201), a Drug Therapy That Delivers a Healthy Version of the Defective Factor VIII Gene Into the Nucleus of Liver Cells Using an Altered, Non-infectious Virus (AAV) as a "Shuttle". Start of enrollment: 2018 Nov 07
- Accelerating COVID-19 Therapeutic Interventions and Vaccines 4 ACUTE Start of enrollment: 2020 Sep 04
Publications & Presentations
PubMed
- 27 citationsHeparin inhibits the intrinsic tenase complex by interacting with an exosite on factor IXa.John P. Sheehan, Catherine E. Kobbervig, Heidi M. Kirkpatrick
Biochemistry. 2003-09-06 - 64 citationsDepolymerized holothurian glycosaminoglycan and heparin inhibit the intrinsic tenase complex by a common antithrombin-independent mechanism.John P. Sheehan, Erik N. Walke
Blood. 2005-11-16 - 24 citationsThe factor IXa heparin-binding exosite is a cofactor interactive site: mechanism for antithrombin-independent inhibition of intrinsic tenase by heparin.Qiu-Ping Yuan, Erik N. Walke, John P. Sheehan
Biochemistry. 2005-02-10
Books/Book Chapters
Committees
- Chair, American Society of Hematology Scientific Commitee on Hemostasis 2013 - 2014
Professional Memberships
- Member
- Member
- International Society for Thrombosis and HaemostasisMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
